6Jin L,Abou MG,Caldwell RB,et al.Endothelial cell dysfunction in a model of oxidative stress[J].Med Sci Monit,2001 ;7(4):585-91
7Yamamoto M,Hara H,Adachi T.Effect of homocysteine on the binding of extracellular superoxide dismutatase to the endothelial cell surface[J].FEBS Lett,2000;486(2):159-62
二级参考文献15
1Refsum H, Ueland P, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med, 1998, 49:31--62.
2Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost, 1999, 81: 165-176.
3Eikelboom J W, Lonn E, Genest J Jr, et al. Homocyst(e)ine and cardiovascular disease.. A critical review of the epidemiologic evidence. Ann Intern Med, 1999,131:363--375.
4Tawakol A, Omland T, Gerhard M, et al. Hyperhomocyst(e) inemia is associated with impaired endotheldependent vasodilation in humans. Circulation, 1997,95:1119--1121.
5Woo K S, Chook P, Lolin Y I, et al. Hyperhomocyst(e) inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation, 1997, 96: 2542-2544.
6Chambers J C, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy. Circulation, 1999, 99: 1156--1160.
7Jacobsen D W, Gatautis V J, Green R, et al. Rapid HPLC determination of total homocysteine and other thiods in serum and plasma : Sex differences and correlation with cobalamin and folate concentration in healthy subjects. Clin Chem, 1994, 40:873--881.
8Spranger M, Krempien S, Schwab S, et al. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury: Correlation with clinical course and infarct size. Stroke, 1997, 28:2425-- 2428.
9Fang J,Madhavan S,Cohen H,et al. Isolated diastolic hypertension: A favorable finding among young and middle-aged hypertensive subject [J]. Hypertension, 1995; 26 : 377-382.
10Lunberg JM,Tatemoto K. Pancreatic polypeptide family(APP、BPP、NPY and PYY) in relation to sympathetic vasoconstriction resistant to α-adrenoceptor blockade [J]. Acad Physiol Scand, 1982;116:392-402.
3Cananeo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost, 1999,81 (2) : 165 - 76.
4Amores -Sanehez MI, Medina MA. Methods for the determination of plasma total homoeystein. Clin Chem Lab Med, 2000,38(3) :199 -204.
5Selhub J ,Jacques PF, Wilson PWF, et al. Vitamins status and intake as primary deteriminaants of homocysteinemia in an elderly population. JAMA, 1993,270(22) :2 693 -2 698.
6Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma of serum:Methods and clinical applications. Clin Chem,1993,39(9) :1 764 - 1 769.
7Boers CHJ. Hyperhomocysteinemia as a rick fator arteria and venous disease a review of evidence and relevance. Trom And Haemos, 1997, 78(1) :580.
10Biselli PM,Guerzoni AR,De Godoy ME. Gene tic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma hom ocysteine and risk of coronary artery disease[J].Thrombosis and Haemostasis,2009.201-204.
